Wird geladen...

Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs

Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Genitourin Cancer
Hauptverfasser: Lee, Chung-Han, Hötker, Andreas M., Voss, Martin H., Feldman, Darren R., Woo, Kaitlin M., Patil, Sujata, Coskey, Devyn T., Akin, Oguz, Hsieh, James J., Motzer, Robert J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/
https://ncbi.nlm.nih.gov/pubmed/26404107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!